Molecular and cellular targets

Ann M Bode1, Zigang Dong

  • 1The Hormel Institute, University of Minnesota, Austin, Minnesota 55912, USA.

Insights

Dietary factors like tea compounds show promise for cancer prevention by targeting molecular pathways. These natural compounds offer potent anticancer activity with low toxicity, aiding in chemoprevention strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Chemoprevention

Background:

  • Carcinogenesis is a multistage process (initiation, promotion, progression) offering targets for chemopreventive agents.
  • Understanding molecular mechanisms of tumor promoter-induced neoplastic transformation is crucial for cancer prevention.
  • Dietary factors, including tea compounds, are increasingly recognized for their potential in cancer prevention and treatment.

Purpose of the Study:

  • To review the effects of tea components on signal transduction pathways involved in neoplastic cell transformation.
  • To explore the potential of dietary factors as chemopreventive agents against cancer.

Main Methods:

  • Review of recent research on tea components and their impact on cancer-related signal transduction pathways.
  • Analysis of molecular and cellular mechanisms underlying carcinogenesis induced by tumor promoters.

Main Results:

  • Tea components modulate signal transduction pathways crucial for neoplastic cell transformation.
  • Dietary compounds, like those in tea, exhibit potent anticancer activity with low toxicity.
  • Natural compounds present a viable strategy for cancer prevention and adjunct therapy.

Conclusions:

  • Tea components influence key signaling pathways in carcinogenesis.
  • Dietary factors offer a promising, low-toxicity approach to cancer chemoprevention.
  • Targeting specific molecular pathways with natural compounds is a key strategy in cancer research.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...